Cytodyn Inc.'s research suggests that CCR5, a receptor on cancer cells, plays a role in the migration and invasion of cells, potentially leading to metastasis, and that blocking CCR5 can reduce invasion and metastasis, especially in the context of glioblastoma stem cells (GSCs) and their phenotypic plasticity.